MiRNA-based therapy for glucose intolerance and insulin resistance: MiRNA-214 increases ß-cell mass and function via down regulation of its target gene, 3/June/2014, 7.36 am

MiRNA-based therapy for glucose intolerance and insulin resistance: MiRNA-214 increases ß-cell mass and function via down regulation of its target gene, 3/June/2014, 7.36 am

MiRNA-based therapy for glucose intolerance and insulin resistance: MiRNA-214 increases ß-cell mass and function via down regulation of its target gene, 3/June/2014, 7.36 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  MiRNA-based therapy for glucose intolerance and insulin resistance: MiRNA-214  increases  ß-cell mass and function via down regulation of its target gene, 3/June/2014, 7.36 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation